
Journal of Heterocyclic Chemistry p. 1355 - 1361 (1996)
Update date:2022-09-26
Topics:
Rosowsky, Andre
Forsch, Ronald A.
Moran, Richard G.
N(α)-[4-[[(4-Aminopteridin-6-yl)methyl]amino]benzoyl]-L-ornithine (dAPA-Orn) was synthesized, and its ability to inhibit folylpolyglutamate synthetase from mouse liver was compared with that of the corresponding 2,4-diamino analogue APA-Orn. Also compared were the inhibitory activities of the deaza analogues 5-deazaAPA-Orn, 8-deazaAPA-Orn, and 5,8-dideazaAPA-Orn, as well as those of N(α)-pteroyl-L-ornithine (PteOrn) and its deaza analogues 5-deazaPteOrn and 5,8-dideazaPteOrn. The inhibition constant K(i) of dAPA-Orn was 7-fold greater than that of APA-Orn, indicating that the 2-amino group plays a role in binding to the active site. The binding affinity of the 2,4-diamino compounds increased in the order 5-deazaAPA < APA-Orn < 5,8-dideazaAPA-Orn < 8-deazaAPA-Orn, and that of the 2-amino-4(3H)-oxo compounds increased in the order 5-deazaPteOrn < Pte-Orn < 5,8-dideazaPteOrn. The most potent inhibitor of both groups was 8-deazaAPA-Orn, with a K(i) of 0.018 μM, corresponding to an 8-fold and 15-fold increase in affinity relative to APA-Orn and 5-deazaAPA-Orn, respectively. The results suggest (a) that the binding of Orn-containing folylpolyglutamate synthetase inhibitors is affected to a greater degree by replacement of N8 by a carbon atom than it is by the corresponding change at N5, (b) that the effect of carbon for nitrogen replacement is greater in the 2,4-diamino derivatives than in the 2-amino-4(3H)-oxo compounds, and (c) that the 2,4-diamines are the better inhibitors. Comparison of the K(i) values of the Orn-containing inhibitors with the K(m) values of the corresponding glutamate-containing substrates revealed that K(m)/K(i) ratio can vary as much as 100-fold depending on the nature of the heterocyclic moiety, suggesting that caution should be exercised in using K(m) values of known substrates to predict K(i) values of putative inhibitors.
View MoreContact:86-15588110016
Address:LINYI CITY,SHANDONG PROVINCE,CHINA
Zhejiang Genebest Pharmaceutical Co.,Ltd.
Contact:0086-571-63532866
Address:No.1 Jinboshi Rd Lishan Town Fuyang City Zhejiang Province China
Chengdu Pukang Biotechnology Co., Ltd
website:http://www.pu-kang.com
Contact:86-028-63976226
Address:No. 868 Xiwang Road,Xinjin county,Chengdu city, China
Chengdu Push Bio-technology Co., Ltd
Contact:--
Address:No.8 Wuke West Second Road, Wuhou
Contact:+86-(0)21-3770 9035
Address:Room 301, Building 2, Meijiabang Road 1508, Shanghai China
Doi:10.1021/ol801601q
(2008)Doi:10.1016/j.tetlet.2006.04.136
(2006)Doi:10.1139/V08-072
(2008)Doi:10.1016/j.tet.2008.06.104
(2008)Doi:10.1021/jo902226t
(2010)Doi:10.1002/jhet.5570230151
(1986)